Blue Trust Inc’s Whitehawk Therapeutics WHWK Stock Holding History

Blue Trust Inc’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-705	Closed	-$5K	–	2723
2023 Q3	$5K	Buy	+705	New	+$4.1K	﹤0.01%	1670

Other funds holding WHWK

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Blue Trust Inc's WHWK Position: Q4 2023 in Review

Blue Trust Inc sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 705 shares — an estimated $5K sold.

Blue Trust Inc first reported a position in WHWK in Q3 2023 and held it in 1 quarter. The position peaked at $5K in Q3 2023. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

Blue Trust Inc reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
Blue Trust Inc sold 705 Whitehawk Therapeutics shares in Q4 2023, an estimated $5K.
Blue Trust Inc first reported a position in Whitehawk Therapeutics in Q3 2023 and held it in 1 quarter.
Blue Trust Inc's Whitehawk Therapeutics position peaked at $5K in Q3 2023.
65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on Blue Trust Inc's 13F filing for Q4 2023, filed 18 Jan 2024.